Skip to main content

Day: August 6, 2021

Aemetis Receives Final Permit to Build Next 21 Miles of Phase 2 Biogas Pipeline

Fully Permitted to Begin Construction of 21 Miles of Phase 2 Biogas Pipeline in Stanislaus County, Calif.  CUPERTINO, CA, Aug. 06, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on below zero carbon intensity products, today announced the final permit has been approved to begin construction of the next 21 miles of the Aemetis Biogas Phase 2 pipeline in Stanislaus County, Calif.  “Issuance of the Phase Two Pipeline county road encroachment permit is a very significant milestone for the Aemetis Biogas RNG project,” said Andy Foster, President of Aemetis Biogas, Inc. “Having now cleared the two major permitting steps required to build the next 21 miles of biogas pipeline, we are poised to rapidly deploy the infrastructure necessary to connect...

Continue reading

Replimune Reports Fiscal First Quarter Financial Results and Provides Corporate Update

Updated complete and durable response data in RP1 (vusolimogene oderparepvec) skin cancer cohorts support the ongoing registration directed development programs in CSCC and anti-PD-1 failed melanoma, with full accrual for both programs expected in mid-2022 Initial data with RP2 as monotherapy and in combination with Opdivo® (nivolumab) in patients with difficult-to-treat and anti-PD-1 failed cancers supports expanding the Phase 1 clinical trial to focus on patients whose tumors have metastasized to the liver A broad Phase 2 program with RP2 and/or RP3 with particular focus on patients with liver metastases from various prevalent cancer types is being designed with the detailed development plan expected to be presented in the first quarter of 2022 Cash at 30 June of $458m with runway into second half of 2024 WOBURN, Mass., Aug. 06, 2021...

Continue reading

PowerFleet Receives 2021 IoT Evolution Asset Tracking Award

PowerFleet LV-500 and LV-710 Honored for Excellent Innovation in Burgeoning Internet of Things Market Segment WOODCLIFF LAKE, N.J., Aug. 06, 2021 (GLOBE NEWSWIRE) — PowerFleet, Inc. (Nasdaq: PWFL), a global leader and provider of subscription-based wireless IoT and M2M solutions for securing, controlling, tracking, and managing high-value enterprise assets, has received the 2021 IoT Evolution Asset Tracking Award for its LV-500 solar tracking solution with the LV-710 freight camera from IoT Evolution World and IoT Evolution Magazine, the leading print and online voices of the high-growth Internet of Things marketplace. The award honors excellence in innovation utilizing IoT technologies to automate asset tracking functions to increase efficiencies, reduce theft, or optimize utilization of the asset. The PowerFleet LV-500 is the...

Continue reading

Icahn Enterprises L.P. Reports Second Quarter 2021 Financial Results

Second quarter net loss attributable to Icahn Enterprises of $136 million, or a loss of $0.53 per depositary unitBoard approves quarterly distribution of $2.00 per depositary unitSUNNY ISLES BEACH, Fla., Aug. 06, 2021 (GLOBE NEWSWIRE) — Icahn Enterprises L.P. (Nasdaq:IEP) is reporting second quarter 2021 revenues of $3.0 billion and net loss attributable to Icahn Enterprises of $136 million, or a loss of $0.53 per depositary unit. For the three months ended June 30, 2020, revenues were $2.7 billion and net income attributable to Icahn Enterprises was $299 million, or $1.36 per depositary unit. For the three months ended June 30, 2021, Adjusted EBITDA attributable to Icahn Enterprises was $192 million compared to $696 million for the three months ended June 30, 2020. For the six months ended June 30, 2021, revenues were $6.4...

Continue reading

10x Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit

PLEASANTON, Calif., Aug. 06, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit. 10x Genomics’ management is scheduled to present on Tuesday, August 10th at 6:00 p.m. Eastern Time/3 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.10xgenomics.com/. About 10x Genomics10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. The company’s integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics...

Continue reading

Newly-designed commemorative t-shirt launches today as part of Rogers 2021 Orange Shirt Day campaign to support residential school survivors

The 2021 Orange Shirt Day campaign will generate proceeds for the Residential School Survivors Society and the Orange Shirt Society TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) — Today, Rogers Communications announced the launch of a new commemorative t-shirt for the 2021 Orange Shirt Day campaign in support of Indigenous communities across the country. Over the past year, the Orange Shirt Day campaign has raised $100,000 for the Orange Shirt Society, a non-profit organization devoted to providing educational toolkits to schools to support teaching the history of residential schools. Starting today, Rogers will make the new 2021 Orange Shirts available on TSC, with all proceeds being divided equally between the Orange Shirt Society and the Residential School Survivors Society (IRSSS), a British Columbia based organization providing...

Continue reading

President & CEO of Nova Leap Health Corp. to Present at the Q3 Virtual Investor Summit

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, Aug. 06, 2021 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), a home health care organization ranked #2 on the 2020 Report on Business ranking of Canada’s Top Growing Companies, is pleased to announce that Chris Dobbin, President & CEO of Nova Leap, will present at the Q3 Virtual Investor Summit event to be held August 17-18, 2021. About the Q3 Virtual Summer Summit The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q3 Investor Summit will take place virtually, featuring 100 companies and over 300 institutional and retail investors. Mr. Chris Dobbin, President & CEO of Nova Leap,...

Continue reading

Cronos Group Appoints Bob Madore as Chief Financial Officer

TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Bob Madore as Chief Financial Officer, effective August 9, 2021, who will succeed Jerry Barbato. “We are pleased to add a leader of Bob’s caliber to the Cronos Group team,” said Kurt Schmidt, President and Chief Executive Officer of Cronos Group. “Bob brings to Cronos Group a proven track record of financial leadership spanning an impressive and diverse 30-year career. His operational capabilities and experience at high profile global consumer brands make him the ideal person to be our next CFO. We look forward to Bob playing a key role in our efforts to capitalize on growth opportunities as Cronos Group continues to execute our regional...

Continue reading

Ocugen Provides Business Update and Second Quarter 2021 Financial Results

        Conference Call and Webcast Today at 8:30 a.m. ETRolling regulatory submission to Health Canada completed and review process initiated; U.S. FDA talks continue Multiple milestones achieved across regulatory and supply chain to support potential commercialization of pipeline assets The Company experienced organizational growth to reflect new business requirements in clinical development, manufacturing, and commercializationMALVERN, Pa., Aug. 06, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today reported second quarter 2021 financial results along with a general business update. “The second quarter has proven...

Continue reading

Parsons Wins Potential $68 Million Multiple-Award Contract for C4ISR Architectures

CENTREVILLE, Va., Aug. 06, 2021 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) has won a $28 million multiple-award contract to support the networks division (Code 55100) at the Naval Warfare Center, Pacific (NIWC Pacific) in engineering and technical services spanning naval, joint, allied and coalition operations. The new contract has a three-year base period with four one-year options for an overall potential value of $68 million and will provide continuing command, control, communications, computer and intelligence surveillance reconnaissance (C4ISR) systems engineering support. “We are proud to support NIWC Pacific in their mission to achieve information dominance in the specialized afloat, ashore and airborne cyberspace domains,” said Christopher Bush, senior vice president of Parsons’ defense business unit. “Our scalable...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.